These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 22995819)
1. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine. White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of cytokine production by hymenialdisine derivatives. Sharma V; Lansdell TA; Jin G; Tepe JJ J Med Chem; 2004 Jul; 47(14):3700-3. PubMed ID: 15214798 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives. Shanab K; Schirmer E; Knafl H; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E Bioorg Med Chem Lett; 2010 Jul; 20(13):3950-2. PubMed ID: 20537894 [TBL] [Abstract][Full Text] [Related]
5. Tetrahydropyrrolo[3,2-c]azepin-4-ones as a new class of cytotoxic compounds. Martínez R; Avila JG; Ramírez MT; Pérez A; Martínez A Bioorg Med Chem; 2006 Jun; 14(12):4007-16. PubMed ID: 16504513 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents. Wang R; Zhang X; Song H; Zhou S; Li S Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents. Alafeefy AM; Ashour AE J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents. Rochais C; Lisowski V; Dallemagne P; Rault S Bioorg Med Chem; 2006 Dec; 14(24):8162-75. PubMed ID: 17011196 [TBL] [Abstract][Full Text] [Related]
9. An array of bengamide E analogues modified at the terminal olefinic position: synthesis and antitumor properties. Martín-Gálvez F; García-Ruiz C; Sánchez-Ruiz A; Valeriote FA; Sarabia F ChemMedChem; 2013 May; 8(5):819-31. PubMed ID: 23512621 [TBL] [Abstract][Full Text] [Related]
10. The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents. Haney KM; Zhang F; Arnatt CK; Yuan Y; Li G; Ware JL; Gewirtz DA; Zhang Y Bioorg Med Chem Lett; 2011 Sep; 21(18):5159-63. PubMed ID: 21820898 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and anticancer activity evaluation of some novel pyrrolo[1,2-a]azepine derivatives. Belal A Arch Pharm (Weinheim); 2014 Jul; 347(7):515-22. PubMed ID: 24729464 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors. Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxicity of novel imidazo[4,5-d]azepine compounds derived from marine natural product ceratamine A. Pan X; Tao L; Ji M; Chen X; Liu Z Bioorg Med Chem Lett; 2018 Mar; 28(5):866-868. PubMed ID: 29433924 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II. Shanab K; Schirmer E; Wulz E; Weissenbacher B; Lassnig S; Slanz R; Fösleitner G; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E Bioorg Med Chem Lett; 2011 May; 21(10):3117-21. PubMed ID: 21458262 [TBL] [Abstract][Full Text] [Related]
15. Photocontrollable sequence-specific DNA alkylation by a pyrrole-imidazole polyamide seco-CBI conjugate. Park S; Bando T; Shinohara K; Nishijima S; Sugiyama H Bioconjug Chem; 2011 Feb; 22(2):120-4. PubMed ID: 21192678 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases. Xu G; Searle LL; Hughes TV; Beck AK; Connolly PJ; Abad MC; Neeper MP; Struble GT; Springer BA; Emanuel SL; Gruninger RH; Pandey N; Adams M; Moreno-Mazza S; Fuentes-Pesquera AR; Middleton SA; Greenberger LM Bioorg Med Chem Lett; 2008 Jun; 18(12):3495-9. PubMed ID: 18508264 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues. Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885 [TBL] [Abstract][Full Text] [Related]
18. Novel approach to bis(indolyl)methanes: de novo synthesis of 1-hydroxyiminomethyl derivatives with anti-cancer properties. Grosso C; Cardoso AL; Lemos A; Varela J; Rodrigues MJ; Custódio L; Barreira L; Pinho e Melo TM Eur J Med Chem; 2015 Mar; 93():9-15. PubMed ID: 25644672 [TBL] [Abstract][Full Text] [Related]
19. "On water" expedient synthesis of 3-indolyl-3-hydroxy oxindole derivatives and their anticancer activity in vitro. Sai Prathima P; Rajesh P; Venkateswara Rao J; Sai Kailash U; Sridhar B; Mohan Rao M Eur J Med Chem; 2014 Sep; 84():155-9. PubMed ID: 25016373 [TBL] [Abstract][Full Text] [Related]
20. Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile. Chiang CC; Lin YH; Lin SF; Lai CL; Liu C; Wei WY; Yang SC; Wang RW; Teng LW; Chuang SH; Chang JM; Yuan TT; Lee YS; Chen P; Chi WK; Yang JY; Huang HJ; Liao CB; Huang JJ J Med Chem; 2010 Aug; 53(16):5929-41. PubMed ID: 20681538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]